共 50 条
- [8] A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation International Journal of Hematology, 2022, 115 : 69 - 76
- [10] Role of Remission Status and Prior Transplant in Optimizing Survival Outcomes Following Allogeneic Hematopoietic Stem Transplantation (HSCT) in Patients Who Received Inotuzumab Ozogamicin for Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S52 - S53